Listed

Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Jun 27, 2020

Filed with the SEC on Jul 31, 2020 and accepted by EDGAR at Jul 31, 2020, 10:33 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-27. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-03-29 to 2020-06-27$6.92bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-27$13.15bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2020-03-29 to 2020-06-27$264.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-27$509.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-03-29 to 2020-06-27$1.71bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-27$3.26bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-03-29 to 2020-06-27$1.39bnus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-27$2.30bnus-gaap:OperatingIncomeLoss
Interest expense3 months2020-03-29 to 2020-06-27$137.0mus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-27$263.0mus-gaap:InterestExpense
Income tax3 months2020-03-29 to 2020-06-27$97.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-27$137.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-03-29 to 2020-06-27$1.16bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income6 months2020-01-01 to 2020-06-27$1.94bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2020-03-29 to 2020-06-27$2.90us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-01 to 2020-06-27$4.87us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-03-29 to 2020-06-27$2.92us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-01 to 2020-06-27$4.91us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-03-29 to 2020-06-27398,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-01 to 2020-06-27399,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-01 to 2020-06-27$2.24bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-27$522.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2020-01-01 to 2020-06-27$163.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2020-01-01 to 2020-06-27$1.50bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-27$5.82bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-27$15.78bnus-gaap:AssetsCurrent
Total assetsAt period end2020-06-27$61.59bnus-gaap:Assets
Current liabilitiesAt period end2020-06-27$6.01bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-06-27$20.64bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-06-27$675.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2020-06-27$29.88bnus-gaap:StockholdersEquity
Shares outstandingAt period end2020-06-27395,589,400 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000097745-20-000038. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.